Activated T cells secret IFNɣ that binds to its receptor IFNɣR1, stimulate neutrophils to support cytotoxic T cell activation, and enhance the tumor microenvironment’s responsiveness to immunotherapy [99]. This evidence concerns the gene IFNA1 and neoplasm.